Stay updated on Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision history now shows v3.4.3 added and v3.4.2 removed.
    Difference
    0.1%
    Check dated 2026-03-12T02:21:42.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history. The funding notice and Revision: v3.4.1 were removed.
    Difference
    0.4%
    Check dated 2026-02-11T11:30:52.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Added a government funding lapse notice with operating status guidance and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:57:30.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    A glossary toggle has been added, and the history diff now uses color-coded highlights for additions (green) and deletions (red). The revision label has been updated to v3.4.0 (from v3.3.4).
    Difference
    0.5%
    Check dated 2026-01-28T05:13:10.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The history shows a minor site revision: Revision: v3.3.4 was added and Revision: v3.3.3 was removed, indicating a backend or UI update rather than changes to the trial data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:37:59.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Footer area updated to include Revision: v3.3.3 and remove HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T10:30:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Pembrolizumab in Melanoma Clinical Trial page.